There is a strong interest in developing obesity treatments based on glucagon-like peptide-1 (GLP-1) agonists, which have proved to limit morbidity and mortality in type 2 diabetes
By inhibiting tyrosinase activity, glutathione decreases melanin production, reducing hyperpigmentation and dark spots
Faustini G, Longhena F, Varanita T, Bubacco L, Pizzi M, Missale C, et al
Activated T cells and macrophages in the synovium form an environment conducive to ferroptosis and inflammation, and also induce ROS production in a positive feedback manner, thus promoting the release of pro-inflammatory factors into the synovium and synovial fluid and further amplifying synovial inflammation (84)
Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis
Lipotropic formulas increase S-adenosyl-methionine and glutathione levels in the liver, supporting detoxification capacity